Her scheme of enlisting foreign governments to stop U.S. mergers suffered a blow Tuesday when Europe’s high court ruled that regulators in Brussels exceeded their authority by blocking Illumina ...

BRUSSELS, Sept 3 (Reuters) - U.S. gene sequencing company Illumina (ILMN.O), opens new tab on Tuesday won its court fight against the European Union's investigation ...

Why has Illumina stock lost one third of its value in the 12 months from August 1, 2023 to August 1, 2024? Why are some scientists, such as those I have heard at genomics conferences, discussing ...

Illumina (NASDAQ: ILMN) a global leader in genomics, and LGC Biosearch Technologies™, a pioneer in agricultural genomics, today announced a strategic partnership to accelerate the adoption of ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Europe’s top court dealt a blow to Brussels regulators on Tuesday after it agreed with US biotech ...

27, 2024 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced Food and Drug Administration (FDA) approval of its in vitro ...

(RTTNews) - Illumina, Inc. (ILMN) Tuesday announced that the 432 million euros fine imposed by the European Commission over GRAIL deal is no longer be payable after favorable verdict by the ...

BRUSSELS (Reuters) -U.S. gene sequencing company Illumina on Tuesday won its court fight against the European Union's investigation of its $7.1 billion purchase of cancer diagnostic test maker Grail, ...

BENGALURU: Illumina, a global leader in DNA sequencing and array-based technologies, announced it will establish a Global CapabilityCenter in Bengaluru to expand its technology workforce in ...

SAN DIEGO - Illumina, Inc. (NASDAQ:ILMN) has fully repaid its obligations under a credit agreement and subsequently terminated the arrangement, according to a recent 8-K filing with the Securities ...

Though Illumina said goodbye to Grail this past summer—after butting heads for years with antitrust regulators and activist investors, while enduring heavy fines and orders to split—the ...

With the recent wrapping up of the World Cancer Congress 2024 in Geneva, Switzerland, and the European Society for Medical ...